GoodRx Holdings (GDRX) Total Current Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Total Current Liabilities across 8 years of filings, most recently posting $1.2 billion for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 784.48% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 784.48% YoY), while the FY2025 annual figure was $246.0 million, up 98.54% from the prior year.
• Total Current Liabilities came in at $1.2 billion for Q2 2026 at GoodRx Holdings, up from $859.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.2 billion in Q2 2026 to a low of $59.4 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $212.7 million, with a median of $115.4 million recorded in 2024.
• Year-over-year, Total Current Liabilities decreased 11.28% in 2025 and surged 784.48% in 2026.
• Over 5 years, Total Current Liabilities stood at $76.3 million in 2022, then jumped by 60.59% to $122.6 million in 2023, then grew by 1.1% to $123.9 million in 2024, then soared by 98.54% to $246.0 million in 2025, then jumped by 370.67% to $1.2 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.2 billion in Q2 2026, $859.2 million in Q1 2026, and $246.0 million in Q4 2025.